FluoroPharma Medical, a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products, announced that its president and CEO, Thijs Spoor, will be presenting at Noble Financial Capital Markets’ Eight Annual Equity Conference.
Mr. Spoor is scheduled to make a presentation to prospective corporate partners and investors on Tuesday, January 17th at 11:30 AM ET. The Company’s presentation will be delivered at the Hard Rock Hotel in Hollywood, Florida.
A live audio and high-definition video webcast of FluoroPharma Medical’s presentation and a copy of the presentation materials will be available on the Events page of the company’s website www.fluoropharma.com as well as through the Noble Financial website www.noblefcm.com. FluoroPharma Medical recommends registering at least 10 minutes before the beginning of the presentation to ensure timely access.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
